Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Infected”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Large-scale testing (Phase 3)UnknownNCT00025727
What this trial is testing

Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure

Who this might be right for
HIV Infections
GlaxoSmithKline 330
Post-approval studies (Phase 4)Ended earlyNCT00598910
What this trial is testing

Effect of Omacor on Triglycerides in HIV Infected Subjects

Who this might be right for
Hyper-Triglyceridemia
Solvay Pharmaceuticals 51
Testing effectiveness (Phase 2)Ended earlyNCT00513513
What this trial is testing

TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 7
Early research (Phase 1)Study completedNCT04592315
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of Lipovirtide in HIV-infected Patients

Who this might be right for
HIV Infections
Shanxi Kangbao Biological Product Co., Ltd. 46
Early research (Phase 1)Study completedNCT00052182
What this trial is testing

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableStudy completedNCT03708640
What this trial is testing

MHealth Physical Activity Trial for Older HIV-infected Adults (mFIT)

Who this might be right for
HIV
Johns Hopkins University 20
Early research (Phase 1)Study completedNCT00503347
What this trial is testing

Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus

Who this might be right for
Hepatitis C VirusHiv Infections
Peregrine Pharmaceuticals 24
Not applicableStudy completedNCT02786758
What this trial is testing

Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals

Who this might be right for
Hepatitis CHIV
Macfarlane Burnet Institute for Medical Research and Public Health Ltd 200
Testing effectiveness (Phase 2)Study completedNCT00004578
What this trial is testing

ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

Who this might be right for
HIV Infections
Abbott 100
Large-scale testing (Phase 3)Study completedNCT00543725
What this trial is testing

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Who this might be right for
HIV InfectionsHIV-1
Tibotec Pharmaceuticals, Ireland 680
Not applicableStudy completedNCT02247999
What this trial is testing

Improving Cervical Cancer Screening Among HIV-Infected Women in India

Who this might be right for
Cervical CancerHIV/AIDSHPV+2 more
National Cancer Institute (NCI) 1,000
Early research (Phase 1)Ended earlyNCT00559416
What this trial is testing

Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy

Who this might be right for
HIV Infections
National Institutes of Health Clinical Center (CC) 14
Large-scale testing (Phase 3)UnknownNCT02961426
What this trial is testing

Strategic Transformation of the Market of HCV Treatments

Who this might be right for
Hepatitis C
Drugs for Neglected Diseases 603
Testing effectiveness (Phase 2)Study completedNCT00549523
What this trial is testing

A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African Adults

Who this might be right for
HIV Infections
University of Missouri-Columbia 133
Not applicableEnded earlyNCT02898896
What this trial is testing

Coronary Artery Disease (CAD) in Suppressed HIV-infected

Who this might be right for
Virus-HIV
University Hospital, Montpellier 62
Large-scale testing (Phase 3)Study completedNCT01034917
What this trial is testing

Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression

Who this might be right for
HIV
Germans Trias i Pujol Hospital 43
Not applicableStudy completedNCT03416790
What this trial is testing

IMPAACT 2015 - Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults With Cognitive Impairment

Who this might be right for
HIV-1-infection
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 24
Testing effectiveness (Phase 2)Study completedNCT00121979
What this trial is testing

Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects

Who this might be right for
HIV Infections
Pharmasset 60
Not applicableStudy completedNCT00346762
What this trial is testing

Evaluating Host and Viral Factors Among HIV Infected Former Commercial Blood Donors in Fuyang, Anhui Province, China

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 186
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation